Asthma, Allergic Completed Phase 1 / 2 Trials for Omalizumab (DB00043)

Back to Asthma, Allergic

Also known as: Atopic Asthma / Allergic Asthma / Asthma extrinsic / Extrinsic asthma / Asthma / Asthma, unspecified / Asthma bronchial / Asthma NOS / Asthmatic / Br. asthma / Bronchitic asthma

Indication	Status	Phase
DBCOND0047182 (Asthma, Allergic)	Completed	1 / 2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01703312	A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma	Treatment	Ligelizumab (DB11856) Omalizumab (DB00043)